Navigation Links
Drugs Taken During Pregnancy Found To Affect Unborn Babies

The lifetime risk for depression in women ranges from 10 percent to 25 percent, with the peak prevalence occurring during // the childbearing years. Some reports suggest as many as 14 percent of pregnant women suffer from depression and up to 35 percent of women use antidepressants during pregnancy. Studies involving infants exposed to SSRIs in the womb have shown few ill effects, so most doctors believe these drugs can be safely prescribed for pregnant women. However, most of these studies have only compared major outcomes, such as physical growth and complications evident on the medical record.

In a recent study researchers found that women who use a serotonin reuptake inhibitor (SSRI) to treat depression or other psychiatric problems during pregnancy may be putting their infants at risk for neurobehavioral problems.

For the study researchers studied 17 full-term newborns whose mothers had taken an SSRI during pregnancy and 17 similar infants whose mothers had not taken one of the drugs, assessing them for more subtle neurobehavioral differences. They found infants exposed to SSRIs in the womb were more likely to have had a shorter gestational age, and were also more likely to suffer from a range of neurobehavioral problems, including nervousness, startles, and sleep disturbances.

Researchers conclude, “Results of the present study call into question the conclusion that SSRI use during pregnancy has little impact on the developing fetus and infant outcome.”
'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs

Post Your Comments:
(Date:11/9/2009)...v. 9 Sutter Health, a family of do...are service providers, is donating $255,000 to foo...ocal food banks will share the quarter-million-dol...tables of thousands of families across the north s...partnering with and supporting charitable programs...
(Date:11/9/2009)...s with drugs that inhibit estrogen, , ,... to treat breast cancer and osteoporosis eliminate...y. , The drugs also cleared precancerous growth...t of cancer in mice with precancerous lesions. ,...t cancer/osteoporosis drug raloxifene were given t...
(Date:11/9/2009)... both eye conditions are age-related, researchers ...-- Cataract surgery doesn,t appear to speed the pr...), according to a new study that challenges the be...s the other. , "Because both conditions are str...also have AMD," wrote Li Ming Dong, of Stony Brook...
(Date:11/9/2009)...9 /PRNewswire-FirstCall/ - Hard To Treat Diseases ...hat Novartis, a US$41 billion international health...1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmac... Switzerland will begin a five-year, $1 billion Ch...matically increase its investment in its China R&a...
(Date:11/9/2009)...sive Cancer Network (NCCN) has posted a draft whit...radigm for near-term comparative effectiveness cli...cument introduces the NCCN Comparative Therapeutic...ompares the risk-versus-benefit of different treat...tice Guidelines in Oncology(TM). The paper will be...
Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4
...hiladelphia, PA, June 25, 2007 State policies hav...y substance abuse treatment programs, and could pl...arch-based "comprehensive" treatment approaches, r...licy proscriptions emanating from scientific resea...
...tem cell research and the potential use of human e...oversial issue which splits both scientific and pu...stem cells throughout the world deals particularly...t. It is a symbolic struggle over the whole future...
...y dose of rivaroxaban cut risk of venous thromboem... (HealthDay News) -- Extended use of the oral drug... clots after hip replacement surgery, British res.... Current guidelines recommend patients receive a ...
...ARBOR, Mich., June 25 HealthMedia(R), Inc.,s,Succ...o-year Health,Information Products (HIP) Certifica...ance (NCQA), the most trusted source for informati...A, since responsibility for adherence to NCQA HRA ...
...cal Division Officer says " ... when we used Jelly...patients from the painful burning and stinging ...act.", SAVANNAH, Ga., June 25 Captain Kevin Carv...at provided,any true relief until he tried Jellyfi...
...R KNOLLS, N.J., June 25 MedeFile,International, I...zing in,portable electronic medical records manage...usive, membership only, resort community located i...ting of over 1,400 members., Members who subscrib...
Other Medicine News:Health News:State policies influence drug treatment programs 2Health News:Stem cell research from an ethical point of view 2Health News:Oral Drug Helps Prevent Clotting After Hip Replacement 2Health News:HealthMedia Health Risk Assessment Earns Prestigious NCQA Certification 2Health News:Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 2Health News:Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 3Health News:Exclusive Resort Community Looks to MedeFile to Provide Members With Access to Medical Records Anytime, Anywhere 2
(Date:11/9/2009)...09 Arena Pharmaceuticals...esults for the third quarter ended September 30, 2...le to common stockholders in the third quarter of ...d to a net loss allocable to common stockholders i...0.76 per share, and a net loss allocable to common...
(Date:11/9/2009)...ov. 9 TessArae® LLC, a global...ons, announces the launch of new integrated produc...hat underlie human hereditary diseases. The combi... resequencing with novel nucleotide sequence basec...reening for all targeted mutations in multiple gen...
(Date:11/9/2009)... AMD LASERS just announced that ind..., has accepted the position of Medical Director. ... overseeing research and development of new soft a...ance for continuing education credits, authoring a...tions, and lecturing and seminar engagements. ,...
Breaking Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9TessArae Delivers Lower Cost Option to Genetic Testing Market 2AMD LASERS Names Dr. James Jesse as Medical Director 2Social Activity Keeps Elders Young Agile 49673 1Social Activity Keeps Elders Young Agile 49673 2Social Activity Keeps Elders Young Agile 49673 3Patients Often Not Told About Abnormal Test Results 49670 1Patients Often Not Told About Abnormal Test Results 49670 2Patients Often Not Told About Abnormal Test Results 49670 3Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 1Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 2
...lleval,University Hospital, Oslo, Norway), lead in...rtic Stenosis (SEAS) Study, will provide an update...ent in London will be Sir Richard Peto (Professor ...ctor of the Clinical Trials Service,Unit, Universi...r of,Medicine and Epidemiology at the University o...
... at the,Nemours Center for Childhood Cancer Resear...s Biomedical Research at the Alfred I. duPont Hosp...r called prostate specific,membrane antigen (PSMA)...ith advanced prostate cancer, has a contributory r...disease. A biomarker is any biomolecule that is,as...
Other Medicine Technology:Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer 2Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer 3
VITOSS Synthetic Cancellous Bone Void Filler
...material composed of Tricalcium Phosphate, which i...of human bone. TCP is an osteoconductive material ...t of bone forming cells and allows for the develop...as between each granule. Conduit TCP strikes the p...
Weitlaner-Locktite retractors
Baby Weitlaner Retractor
Medicine Products: